Table 4.
Clavien-Dindo characteristics (by race)
| Asian (N = 985) | Black (N = 36,970) | Hispanic (N = 28,673) | Other (N = 1335) | White (N = 145,007) | Total (N = 212,970) | |
|---|---|---|---|---|---|---|
| Clavien-Dindo Grade I | 33 (3.4%) | 1984 (5.4%) | 1232 (4.3%) | 62 (4.6%) | 5942 (4.1%) | 9253 (4.3%) |
| Superficial incisional SSI | 9 (0.9%) | 146 (0.4%) | 139 (0.5%) | 10 (0.7%) | 966 (0.7%) | 1270 (0.6%) |
| Dehydration treatment | 11 (2.2%) | 1118 (5.8%) | 570 (3.8%) | 33 (5.0%) | 3099 (4.2%) | 4831 (4.4%) |
| Emergency department visit | 23 (4.5%) | 1599 (8.2%) | 1015 (6.7%) | 56 (8.5%) | 4559 (6.1%) | 7252 (6.6%) |
| Peripheral nerve injury | 0 (0.0%) | 1 (0.0%) | 0 (0.0%) | 0 (0.0%) | 12 (0.0%) | 13 (0.0%) |
| Clavien-Dindo Grade II | 13 (1.3%) | 466 (1.3%) | 334 (1.2%) | 22 (1.6%) | 1940 (1.3%) | 2775 (1.3%) |
| Pneumonia | 6 (0.6%) | 254 (0.7%) | 214 (0.7%) | 6 (0.4%) | 1065 (0.7%) | 1545 (0.7%) |
| Blood transfusion | 9 (0.7%) | 356 (0.7%) | 278 (0.7%) | 13 (0.7%) | 1461 (0.7%) | 2117 (0.7%) |
| Urinary tract infection | 6 (0.6%) | 138 (0.4%) | 97 (0.3%) | 7 (0.5%) | 560 (0.4%) | 808 (0.4%) |
| VTE requiring treatment | 1 (0.1%) | 85 (0.2%) | 67 (0.2%) | 3 (0.2%) | 315 (0.2%) | 471 (0.2%) |
| Anticoagulation for VTE/PE | 3 (0.3%) | 210 (0.6%) | 134 (0.5%) | 6 (0.4%) | 659 (0.5%) | 1012 (0.5%) |
| Clostridium difficile | 0 (0.0%) | 25 (0.1%) | 9 (0.1%) | 2 (0.3%) | 156 (0.2%) | 192 (0.2%) |
| Clavien-Dindo Grade III | 22 (2.2%) | 1248 (3.4%) | 1213 (4.2%) | 27 (2.0%) | 3987 (2.7%) | 6497 (3.1%) |
| Wound disruption | 1 (0.1%) | 22 (0.1%) | 27 (0.1%) | 1 (0.1%) | 82 (0.1%) | 133 (0.1%) |
| Incisional hernia | 1 (0.1%) | 29 (0.1%) | 17 (0.1%) | 1 (0.1%) | 140 (0.1%) | 188 (0.1%) |
| Deep incisional SSI | 0 (0.0%) | 31 (0.1%) | 19 (0.1%) | 2 (0.1%) | 135 (0.1%) | 187 (0.1%) |
| Organ/space SSI | 2 (0.2%) | 68 (0.2%) | 68 (0.2%) | 2 (0.1%) | 417 (0.3%) | 557 (0.3%) |
| Drain placement after 30 days | 2 (0.2%) | 60 (0.2%) | 464 (1.6%) | 1 (0.1%) | 301 (0.2%) | 828 (0.4%) |
| Reoperation within 30 days | 11 (1.1%) | 595 (1.6%) | 396 (1.4%) | 16 (1.2%) | 2122 (1.5%) | 3140 (1.5%) |
| Intervention within 30 days | 14 (1.4%) | 810 (2.2%) | 469 (1.6%) | 18 (1.3%) | 2320 (1.6%) | 3631 (1.7%) |
| Clavien-Dindo Grade IV | 3 (0.3%) | 236 (0.6%) | 100 (0.3%) | 4 (0.3%) | 780 (0.5%) | 1123 (0.5%) |
| Acute renal failure | 2 (0.2%) | 35 (0.1%) | 13 (0.0%) | 0 (0.0%) | 112 (0.1%) | 162 (0.1%) |
| Progressive renal insufficiency | 1 (0.1%) | 55 (0.1%) | 15 (0.1%) | 2 (0.1%) | 104 (0.1%) | 177 (0.1%) |
| Myocardial infarction | 2 (0.2%) | 8 (0.0%) | 8 (0.0%) | 1 (0.1%) | 70 (0.0%) | 89 (0.0%) |
| Stroke/CVA | 0 (0.0%) | 5 (0.0%) | 1 (0.0%) | 0 (0.0%) | 19 (0.0%) | 25 (0.0%) |
| Ventilator > 48 h | 0 (0.0%) | 2 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (0.0%) | 3 (0.0%) |
| Unplanned intubation | 1 (0.1%) | 77 (0.2%) | 24 (0.1%) | 2 (0.1%) | 284 (0.2%) | 388 (0.2%) |
| Pulmonary embolism | 1 (0.1%) | 67 (0.2%) | 25 (0.1%) | 1 (0.1%) | 157 (0.1%) | 251 (0.1%) |
| Cardiac arrest | 0 (0.0%) | 15 (0.0%) | 7 (0.0%) | 1 (0.1%) | 52 (0.0%) | 75 (0.0%) |
| Coma > 24 h | 0 (0.0%) | 4 (0.0%) | 1 (0.0%) | 0 (0.0%) | 9 (0.0%) | 14 (0.0%) |
| Sepsis | 0 (0.0%) | 39 (0.1%) | 31 (0.1%) | 4 (0.3%) | 192 (0.1%) | 266 (0.1%) |
| Septic shock | 0 (0.0%) | 40 (0.1%) | 31 (0.1%) | 4 (0.3%) | 198 (0.1%) | 273 (0.1%) |
| Clavien-Dindo Grade V | 2 (0.2%) | 46 (0.1%) | 13 (0.0%) | 2 (0.1%) | 143 (0.1%) | 206 (0.1%) |
| 30-day mortality | 2 (0.2%) | 46 (0.1%) | 13 (0.0%) | 2 (0.1%) | 143 (0.1%) | 206 (0.1%) |